---
title: 'Use of chemotherapy and loco-regional therapy in stage IA triple-negative
  breast cancer and their association with oncologic outcomes: A cancer registry study'
date: '2024-09-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39291633/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240918184842&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: We aimed to evaluate the role of adjuvant chemotherapy and loco-regional
  therapy for stage IA (pT1, pN0) triple-negative breast cancer (TNBC) in a real-world
  setting. We identified patients with pT1, pN0 TNBC diagnosed between 2009 and 2021
  within the Baden-Württemberg cancer registry (BWCR), Germany. Overall survival (OS)
  was assessed using Kaplan-Meier statistics and multivariate Cox regression models
  (adjusted for age, use of chemotherapy, local therapy (breast conserving therapy
  ...
disable_comments: true
---
We aimed to evaluate the role of adjuvant chemotherapy and loco-regional therapy for stage IA (pT1, pN0) triple-negative breast cancer (TNBC) in a real-world setting. We identified patients with pT1, pN0 TNBC diagnosed between 2009 and 2021 within the Baden-Württemberg cancer registry (BWCR), Germany. Overall survival (OS) was assessed using Kaplan-Meier statistics and multivariate Cox regression models (adjusted for age, use of chemotherapy, local therapy (breast conserving therapy ...